Infertility Drugs Market by Product and Geography - Forecast and Analysis 2021-2025

  • Published: May 2021
  • Pages: 120
  • SKU: IRTNTR41375

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The infertility drugs market has the potential to grow by USD 1.05 billion during 2021-2025, and the market’s growth momentum will accelerate at a CAGR of 4.75%.

This infertility drugs market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers market segmentation by product (hormone-based therapy and others) and geography (North America, Europe, Asia, and ROW). The infertility drugs market report also offers information on several market vendors, including Abbott Laboratories, AbbVie Inc., Bayer AG, Ferring Pharmaceuticals AS, GlaxoSmithKline Plc, Merck and Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., and Sanofi SA among others.

What will the Infertility Drugs Market Size be in 2021?


Browse TOC and LoE with selected illustrations and example pages of Infertility Drugs Market

 Get Your FREE Sample Now!

Infertility Drugs Market: Key Drivers and Trends

Based on our research output, there has been a positive impact on the market growth during and post COVID-19 era. The growing lifestyle diseases is notably driving the infertility drugs market growth, although factors such as rising inclination toward other modes of treatment for infertility may impede market growth. To unlock information on the key market drivers and the COVID-19 pandemic impact on the infertility drugs industry get your FREE report sample now.

  • The increasing lifestyle diseases will drive the growth of the infertility drugs market.
  • Lifestyle diseases such as obesity, diabetes, and high blood pressure are some of the high potential factors leading to infertility.
  • There is a rising prevalence rate of diabetes in the younger population, specifically those lying in the reproductive age group of 18-45 years, which, in turn, leads to higher cases of infertility and will demand a higher volume of infertility drugs. 
  • Rising cases of obesity are expected to bring a higher number of infertility cases and hence would act as a major factor leading to the growth of the global infertility drugs market. 
  • The growing online retail sales of drugs, one of the key infertility drugs market trends, will influence market growth.
  • Online purchase of drugs has become easy and less time-consuming, which is supported by the high penetration of the Internet and smartphones.
  • Online retailing will be the fastest mode of distribution of sexual disorder-related drugs among all different retail channels in the coming years.
  • The factors responsible for the success of online retailing are the availability of a broad range of products, quick delivery services, and highly competitive prices. 

This infertility drugs market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. Get detailed insights on the trends and challenges, which will help companies evaluate and develop growth strategies.

Who are the Major Infertility Drugs Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:


  • Abbott Laboratories
  • AbbVie Inc.
  • Bayer AG
  • Ferring Pharmaceuticals AS
  • GlaxoSmithKline Plc
  • Merck and Co. Inc.
  • Merck KGaA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA


The infertility drugs market is fragmented and the vendors are deploying growth strategies such as expanding their research into developing new formulations of the existing drugs to compete in the market. Click here to uncover other successful business strategies deployed by the vendors. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

Download a free sample of the infertility drugs market forecast report for insights on complete key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies. 

Which are the Key Regions for Infertility Drugs Market?


For more insights on the market share of various regions Request for a FREE sample now!

38% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for infertility drugs in North America. Market growth in this region will be faster than the growth of the market in Europe.

The complications associated with late-age pregnancies will facilitate the infertility drugs market growth in North America over the forecast period. To garner further competitive intelligence and regional opportunities in store for vendors, view our sample report.

What are the Revenue-generating Product Segments in the Infertility Drugs Market?


To gain further insights on the market contribution of various segments Request for a FREE sample

The infertility drugs market share growth by the hormone-based therapy segment will be significant during the forecast period. Different hormone-based treatments have been worked on aiming to improve the infertile condition among males and females. The easy availability of hormone-based therapy and high acceptance of the treatment has led to the high market share of the segment in the infertility drugs market.

Fetch actionable market insights on post COVID-19 impact on each segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the infertility drugs market size.



Request for a FREE sample

What are the Key Factors Covered in this Infertility Drugs Market Report?

  • CAGR of the market during the forecast period 2021-2025
  • Detailed information on factors that will drive infertility drugs market growth during the next five years
  • Precise estimation of the infertility drugs market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the infertility drugs industry across North America, Europe, Asia, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of infertility drugs market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.


Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases


Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts



  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis


  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
The infertility drugs market growth will increase by $1038.44 million during 2019-2024.
The infertility drugs market is expected to grow at a CAGR of 4.82% during 2019-2024.
Technavio has segmented the infertility drugs market by product (Hormone-based therapy and Others) ,application (Transportation, Machinery, Metal fabrication, Consumer goods, and Others) , and geographic (North America, Europe, APAC, and South America).
AbbVie Inc., Allergan Plc, Bayer AG, Ferring Pharmaceuticals AS, GlaxoSmithKline Plc, Merck & Co. Inc., Merck KGaA, Novartis AG, Pfizer Inc., Sanofi are a few of the key vendors in the infertility drugs market.
North America will register the highest growth rate of 36.33% among the other regions. Therefore, the infertility drugs market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
The key factors driving the infertility drugs market growth are:
  • Growing lifestyle diseases
  • Raising awareness regarding infertility in couples
The infertility drugs market vendors should focus on grabbing business opportunities from the hormone-based therapy segment as it accounted for the largest market share in the base year.

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase

Technavio's SUBSCRIPTION platform

Register for a free trial today and gain instant access to 17,000+ market research reports.


Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Report

What other custmores say

17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>